The healthcare sector is undergoing a profound structural evolution as artificial intelligence (AI) transitions from an assistive, reactive tool into an autonomous execution layer. According to financial assessments, global AI expenditure is projected to rise from $1.76 Trillion in 2025 to $2.52 Trillion in 2026, before reaching $3.34 Trillion in 2027. A significant concentration of venture capital is driving this transformation; AI firms raised approximately $242 Billion in

The European healthtech and medtech sectors have entered a phase of disciplined maturity, transitioning away from the venture subsidised experimentation of the early 2020s toward an era characterised by industrialisation and regulatory Darwinism. In the current market environment of 2025 and 2026, the criteria for a successful Series A funding round have shifted fundamentally. Investors no longer prioritise raw user acquisition or speculative growth; instead, they demand a ri